Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, proudly presented awards to seven outstanding volunteer leaders whose impact has ...

Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, today announced the launch of Project ACT (Accelerate Cell Therapies), a flagship ...

Why T1D screening matters. According to the T1D Index, an estimated 1.6 million people in the U.S. are living with T1D — an autoimmune disease wherein the pancreas makes little to no insulin.

A new antibody testing strategy using tissue transglutaminase antibodies at 6.1 times the upper limit of normal can improve celiac disease diagnosis in patients with T1D, according to a Swiss study.

The Breakthrough T1D program focuses on cures for Type 1 diabetes, a disease which strikes one in 400 children. More than 1.6 million Americans have Type 1 diabetes (T1D), and 9.4 million have it ...

Statement from Aaron J. Kowalski, PhD, CEO of Breakthrough T1D, Formerly JDRF, the Leading Global Type 1 Diabetes Research and Advocacy Organization, on NIH Indirect Costs Cuts.

In type 1 diabetes (T1D), the body’s immune system attacks the pancreas, resulting in it making little or no insulin. A combination of genetics and environmental factors, ...